Clinical Trial Update: Efficacy and Safety of Desmopressin (Nocturin®) 0.1 mg Tablets in Treatment of Nocturia in Participants With Benign Prostate Syndrome (BPS)

View source ↗

Summary

This clinical trial update reports the efficacy and safety of desmopressin 0.1 mg tablets for treating nocturia in men with Benign Prostate Syndrome, with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Nocturia
• Nocturnal Polyuria

Drugs mentioned

• Nocturin (desmopressin)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Nocturia Associated With Nocturnal Polyuria | Status: COMPLETED | Results posted: 2011-04-11